Hidefumi Kasuga is currently an Investment Director at Taiho Ventures, LLC, where they have been involved in deal sourcing, evaluation, and portfolio support since 2022. Prior to this role, they spent nine years at Taiho Pharmaceutical Co., Ltd., working as a scientist in a global product development team focused on oncology. Hidefumi's expertise includes managing pre-clinical pharmacology teams and conducting extensive drug target validation. They also serve as a Board Observer for Normunity and Incendia Therapeutics. Hidefumi holds a Ph.D. in Pharmaceutical Sciences from The University of Tokyo.
This person is not in the org chart
This person is not in any teams
This person is not in any offices